Caspase-8 deficiency induces a switch from TLR3 induced apoptosis to lysosomal cell death in neuroblastoma

Archive ouverte

Locquet, Marie-Anaïs | Ichim, Gabriel | Bisaccia, Joseph | Dutour, Aurelie | Lebecque, Serge | Castets, Marie | Weber, Kathrin

Edité par CCSD ; Nature Publishing Group -

International audience. In cancer cells only, TLR3 acquires death receptor properties by efficiently triggering the extrinsic pathway of apoptosis with Caspase-8 as apical protease. Here, we demonstrate that in the absence of Caspase-8, activation of TLR3 can trigger a form of programmed cell death, which is distinct from classical apoptosis. When TLR3 was activated in the Caspase-8 negative neuroblastoma cell line SH-SY5Y, cell death was accompanied by lysosomal permeabilization. Despite caspases being activated, lysosomal permeabilization as well as cell death were not affected by blocking caspase-activity, positioning lysosomal membrane permeabilization (LMP) upstream of caspase activation. Taken together, our data suggest that LMP with its deadly consequences represents a “default” death mechanism in cancer cells, when Caspase-8 is absent and apoptosis cannot be induced.

Suggestions

Du même auteur

Characterization of cellular 3D models of chordoma and evaluation of a radiosensitizing approach. Validation de modèles 3D de chordome et preuves de concept in vitro d’une stratégie radiosensibilisante

Archive ouverte | Locquet, Marie-Anaïs | CCSD

Chordomas are rare slow growing tumors of the axial skeleton. These tumors are locally aggressive, refractory to conventional therapies, and currently untreatable. Radical surgery and radiations remain the first-line treatments. D...

Radiotherapy in bone sarcoma: the quest for better treatment option

Archive ouverte | Locquet, Marie-Anaïs | CCSD

International audience. Bone sarcomas are rare tumors representing 0.2% of all cancers. While osteosarcoma and Ewing sarcoma mainly affect children and young adults, chondrosarcoma and chordoma have a preferential i...

Aldehyde Dehydrogenase, a Therapeutic Target in Chordoma: Analysis in 3D Cellular Models

Archive ouverte | Locquet, Marie-Anaïs | CCSD

International audience. Chordomas are rare, slow-growing tumors of the axial skeleton. These tumors are locally aggressive and refractory to conventional therapies. Radical surgery and radiation remain the first-lin...

Chargement des enrichissements...